Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 58

Advances in Cancer Prevention received 58 citations as per Google Scholar report

Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Euro Pub
  • ICMJE
Share This Page

Kouya Shiraishi

Kouya Shiraishi
Kouya Shiraishi
Professor
Kitasato University
Japan
Phone:+81-3-3542-2511
FAX:+81-3542-0807
Kitasato University

Biography

As a staff scientist at National Cancer Research institute in Japan, I am currently responsible for the laboratory-based research. My research interest has been focus on understanding the molecular mechanism of lung carcinogenesis. Lung cancer is the leading cause of cancer death both in Asian and Western countries. In particular, the proportion of females and never smokers among lung adenocarcinoma patients is considerably higher in Asians than in Europeans, suggesting that Asians experience a distinct effect of genetic factors than Europeans. I and our collaborators performed a genome-wide association study (GWAS) of lung adenocarcinoma in the Japanese population. In a series of publications [Nature Genetics 2012, 44: 900, Nature Genet. 2012, 44: 1330], two lung adenocarcinoma susceptibility genes, BPTF at 17q24.3 and BTNL2 at 6p21.3 were identified.

Research Interest

Lung cancer
Genome-wide association study
Gene–environment interaction

Certificate

Certificate

Publications

An Overview of Genetic Polymorphism and Lung Cancer Risk

Kouya Shiraishi, Takayuki Honda and Takashi Kohno
Review Article: Adv Cancer Prev 2016, 1: 106
DOI: 10.4172/2472-0429.1000106
Relevant Topics
Top